Balsalazide ( DrugBank: Balsalazide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	5

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00486031 (ClinicalTrials.gov)	October 2006	11/6/2007	Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study	A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalaz ...	Inflammatory Bowel Disease;Ulcerative Colitis	Drug: Balsalazide Disodium	Bausch Health Americas, Inc.	NULL	Completed	18 Years	N/A	All	443	Phase 3	United States
2	NCT00408174 (ClinicalTrials.gov)	May 2006	4/12/2006	Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis	A Multicenter, Randomized, Double-Blind, Actively-Controlled Trial to Evaluate the Safety and Effica ...	Inflammatory Bowel Disease;Ulcerative Colitis	Drug: Balsalazide disodium	Bausch Health Americas, Inc.	NULL	Completed	18 Years	N/A	All	400	Phase 3	United States
3	NCT00269438 (ClinicalTrials.gov)	December 2005	22/12/2005	New Tablet Formulation and Dosing Regimen of BalsalazideDisodium in Mildly to Moderately Active Ulce ...	Phase 3 Study to Establish the Efficacy and Safety of a New Tablet Formulation and Dosing Regimen of ...	Ulcerative Colitis	Drug: 5 ASA, enemas, suppositories, corticosteroids	Bausch Health Americas, Inc.	NULL	Completed	18 Years	80 Years	All	225	Phase 3	United States
4	NCT00618202 (ClinicalTrials.gov)	May 2005	30/1/2008	A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of BalsalazideDisodium 75 ...	A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of BalsalazideDisodium 75 ...	Ulcerative Colitis	Drug: Balsalazide	Roxane Laboratories	NULL	Completed	18 Years	45 Years	All	52	N/A	United States
5	NCT00618228 (ClinicalTrials.gov)	January 2004	30/1/2008	Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions	A Single Dose, Two-Period, Two-Treatment, Randomized Crossover Bioequivalency Study of 750 mg Balsal ...	Ulcerative Colitis	Drug: Balsalazide	Roxane Laboratories	NULL	Completed	18 Years	45 Years	All	52	N/A	United States

First Previous1Next Last